Skip to content
Main menu hidden.


A challenge to find the solution to pancreatic cancer

Pancreatic cancer can resist most existing treatments and the five-year survival rate is low.

Targeting cancer cells without affecting healthy cells

Francesca Aguilos work lies at the cutting edge of biomedical research and cancer.

Genetically modified fish assisting in the fight against cancer

Marléne Landström's research could lead to better treatment and more effective drugs to treat prostate cancer.

Research infrastructures

Umeå Centre for Comparative Biology (UCCB)
Biomedical research on experimental animals at Umeå University is organized within Umeå Centre for Comparative Biology (UCCB).


Breakthrough in the understanding of a protein with a key role in cancer

The neutron reflexometry method gives scientists atomic-level insight into the behaviour of the protein Bcl-2.

Novel insights of how prostate cancer causes secondary tumors

Awareness of how prostate cancer cells become mobile and spread may provide opportunities for treatment.

Medicine against prostate cancer in new COVID-19 study

Researchers will investigate if a medicine for prostate cancer also can have effect on COVID-19.

Doctoral thesis: Growth factor signaling cross-talk contribute to cancer progression

In cancer the synergistic cross-talk between the proteins contributes to cancer progression.

An epigenetic marker can predict survival in childhood leukaemia

Risk of relapse in childhood leukemia can be predicted which will make tailoring treatment possible.

Motor enzyme protects genome through several mechanisms

A helicase, Pfh1, can protect the genome from DNA obstacles and damages associated with cancer.

Research projects

Prostate cancer therapy for COVID-19
Duration 8 June 2020 until 31 May 2022
Type of project Research project
Artificial intelligence in oncology: European REVERT
Duration 1 January 2020 until 31 December 2023
Type of project Research project
The BRECLIM trial
Research area: Cancer, Clinical medicine
Duration 1 January 2020 until 31 December 2029
Type of project Research project
The DIRECT-study - Disclosure of genetic risk to prevent cancer
Duration 2 September 2019 until 31 December 2021
Type of project Research project
Design and evaluation of technique and nursing care in pediatric radiotherapy
Duration 13 May 2016 until 31 December 2016
Type of project Research project

Research groups

Andrei Chabes Lab
dNTPs and maintenance of genome stability.
Anna Arnqvist Lab
We study mechanisms for stochastic and tightly controlled regulation of Helicobacter pylori adhesins.
Beatrice Melin
Research group Beatrice Melin
Research area: Cancer
Francesca Aguilo
RNA-based gene regulation of cell fate and breast cancer
Research area: Cancer
Gerhard Gröbner Lab
NMR methods to understand the function of biological membranes, their proteins and role in various diseases.
Henrik Antti Lab
Research area: Cancer
Jan Larsson Lab
The research group is studying chromosome-specific gene regulation and chromosome specific adaptations.
Jenny Persson
Cancer metastasis and targeted therapies.
Research area: Cancer
Johan Henriksson Lab
Our group aims at integrating all regulatory mechanisms about T cells in a single predictive model
Jonas von Hofsten-research group
Muscle development and regeneration.
Research area: Cancer, Molecular medicine
Karin Nylander
Studies of squamous cell carcinoma of the mobile tongue using tissue, blood and artificial intelligence
Research area: Cancer
Lena Gunhaga
Early development of the nervous system
Lena Svensson Lab
Our research group is interested in how to understand how integrins are regulated and reused.
Research area: Cancer, Infection biology